Hjem › Prostatakræft › Alabama
Prostatakræft kliniske forsøg i Alabama
12 studier for Prostatakræft søger deltagere på steder i Alabama.
Byer i Alabama
Officiel studietekst (engelsk)
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Alabama at Birmingham Cancer Center, Birmingham
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06632977DESTINY-PANTUMOUR04
- Research Site, Birmingham
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 24. sep. 2026 · NCT07028853Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Urology Centers Of Alabama Pc, Homewood
RekruttererFase 3
Alder 18 til 100 · Mænd · Opdateret 22. sep. 2026 · NCT06855277Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- University of Alabama at Birmingham, Birmingham
Rekrutterer
Alder 18 og opefter · Mænd · Opdateret 14. sep. 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- University of Alabama Birmingham Hospital, Birmingham
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 11. sep. 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
- The Kirklin Clinic at Acton Road, Birmingham
- Lewis and Faye Manderson Cancer Center, Tuscaloosa
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 10. sep. 2026 · NCT05946213A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Clearview Cancer Institute, Huntsville
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 3. sep. 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Dothan
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 26. aug. 2026 · NCT07611110Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Alabama at Birmingham Hospital, Birmingham
RekruttererFase 1
Alder 18 til 100 · Mænd · Opdateret 13. aug. 2026 · NCT05519449International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Alabama- Tuscaloosa, Tuscaloosa
RekruttererObservationsstudie
Alder 21 og opefter · Mænd · Opdateret 22. maj 2026 · NCT03151629SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.